Results
In-person events
Out-of-Office Live
Speaker:
Chad Reichard, MD
The Capital Grille, 2000 East Golf Road, Schaumburg, IL 60173
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Katie Murray, DO, MS, FACS
BlueStone, 11 w. Aylesbury Road, Timonium, MD 21093
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Chad Reichard, MD
Wildfire, 232 Oakbrook Center, Oak Brook, IL 60523
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Ravi Chauhan, MD
Ruth's Chris Steak House, 2727 E. 86Th Street, Indianapolis, IN 46240
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Ravi Chauhan, MD
The Hideaway Beverly Hills, 421 N Rodeo Dr, Ste G18, Beverly Hills, CA 90210
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
In-Office Live
Speaker:
Patrick J. Hensley, MD
The Urology Group - Norwood, 2000 Joseph E Sanker Boulevard, Cincinnati, OH 45212
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Ravi Chauhan, MD
Meat Market Boca Raton Steakhouse, 2000 NW 19th Street, Boca Raton, FL 33431
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
In-Office Live
Speaker:
Chad Reichard, MD
Idaho Urologic Institute, 2855 E Magic View Dr., Meridian, ID 83642
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Lawrence Karsh, MD, FACS, CPI
Hilton Phoenix at the Peak, 7677 N 16th St., Phoenix, AZ 85020
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Online events
Hybrid (Speaker Remote)
Speaker:
Gautam Jayram, MD
Location:
Urology Associates of the Central Coast, 225 Prado Rd, Ste D, San Luis Obispo, CA 93401
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Hybrid (Speaker Remote)
Speaker:
Gautam Jayram, MD
Location:
Center Square Grill, 84 Center Square, East Longmeadow, MA 01028
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Virtual (Fully Remote)
Speaker:
Gautam Jayram, MD
Location:
Garden State Urology, 16 Eden Ln, Whippany, NJ 07981
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.